Biotek-snakken — Maj 2023
-
Transcript fra Q&A med CEO Adam Steensberg fra Zealand Pharma d. 24. maj 2023 https://www.proinvestor.com/boards/112798
-
STENOCARE-PRODUKT ER GODKENDT OG KLAR TIL SALG I TYSKLAND https://www.proinvestor.com/boards/112800
-
Kort video: Genmab ' GN Store Nord ' Zealand Pharma ' Brain+ ' Stenocare https://www.proinvestor.com/boards/112810
-
@Fandel - jeg kan ikke finde noget ... Det var Ascelia Pharma som jeg havde købt til lige omkring kurs 15. Den bliver kørt op og ned som vinden blæser og på næsten samme måde som Hansa Biopharma, så læg ikke noget i dagens kursstigning. Men virkelig en spændende case ... hvor oddsene er relativ gode ifg. Redeye, Erik Penser Bank og fx tidl. kursmål fra Danske Bank Lars H.
-
HC Wainwright & Co. Reiterates Gracell Biotechnologies Inc - ADR (GRCL) Buy Recommendation
https://www.proinvestor.com/investornyt/992557/hc-wainwright-amp-co-reiterates-gracell-biotechnologies-inc-adr-grcl-buy-recommendation -
UPDATE: FDA needs more time for Sarepta's DMD gene therapy—spurring a deja vu of Exondys 51
(May 24, 2023 08:39am)
"The FDA needs a wee bit more time to consider the approval of Sarepta Therapeutics' gene therapy for Duchenne muscular dystrophy (DMD), however, the agency has indicated an accelerated approval is likely in a restricted age group."
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind